hariemmadi
●    

2007-10-25 14:14
(6821 d 12:01 ago)

Posting: # 1254
Views: 5,805
 

 intrasubject variability for clonazepam [Design Issues]

i would like to know the intra-subject variability for clonazepam, is tweleve volunteers are enough to conduct the be study


Edit: Category changed. [Helmut]
ashutoshkumaryadav
☆    

Ahmedabad, India,
2008-05-06 16:44
(6627 d 09:31 ago)

@ hariemmadi
Posting: # 1820
Views: 4,491
 

 intrasubject variability for clonazepam

Dear Hariemmadi,

The maximum ISCV observed in literature is approximately 12 % for cmax. Based on that 12 subjects are sufficient to prove bioequivalence with 80 % power. However considering the dropouts better to enroll two extra subjects.

Thanks and regards
Ashutosh Kumar Yadav
M.Pharm (Pharmacology)
Mob. No. +91-079-9904516032
MGR
★    

India,
2008-05-08 12:45
(6625 d 13:30 ago)

@ hariemmadi
Posting: # 1833
Views: 4,375
 

 intrasubject variability for clonazepam

Hi Hariemmadi,

According to the Intrasubject CV twelve volunteers are ok. But you have to look after the ratio's (point estimate) also. Considering the ratios also, we have to decide the sample size. For suppose if the ratios you are getting around 90 or 110 then the sample size will be more. So be caution regarding this.

Thank you.

Regards,
MGR
UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
368 visitors (0 registered, 368 guests [including 22 identified bots]).
Forum time: 02:15 CEST (Europe/Vienna)

Most scientists today are devoid of ideas, full of fear, intent on
producing some paltry result so that they can add to the flood
of inane papers that now constitutes “scientific progress”
in many areas.    Paul Feyerabend

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5